Lazard Says Sell Cyberonics Inc. (CYBX) Ahead of Friday's FDA Advisory Panel Meeting
Tweet Send to a Friend
Lazard its telling clients to sell Cyberonics Inc. (Nasdaq: CYBX) ahead of Friday's neurologic devices FDA advisory panel meeting ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE